Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $1000.0.

  • Traws Pharma's Other Working Capital Changes rose 10031.65% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 62464.99%. This contributed to the annual value of -$226000.0 for FY2024, which is 11793.65% down from last year.
  • Per Traws Pharma's latest filing, its Other Working Capital Changes stood at $1000.0 for Q3 2025, which was up 10031.65% from -$2.0 million recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Other Working Capital Changes peaked at $1.0 million during Q3 2023, and registered a low of -$2.0 million during Q2 2025.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$76000.0 (2024), whereas its average is -$108263.2.
  • As far as peak fluctuations go, Traws Pharma's Other Working Capital Changes surged by 69266.67% in 2022, and later tumbled by 535135.14% in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's Other Working Capital Changes stood at -$337000.0 in 2021, then tumbled by 62.91% to -$549000.0 in 2022, then surged by 113.11% to $72000.0 in 2023, then surged by 181.94% to $203000.0 in 2024, then crashed by 99.51% to $1000.0 in 2025.
  • Its Other Working Capital Changes stands at $1000.0 for Q3 2025, versus -$2.0 million for Q2 2025 and -$774000.0 for Q1 2025.